{"transactions":[{"id":4638101,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":70563,"kind":"person","name":"Narula Sanjeev","position":1,"cik":"0001820590","reported_name":"Narula Sanjeev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2026-10-08T21:44:35.000Z","date":"2026-10-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":13485,"price":6.78,"value":91428.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying the restricted stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,488 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2026."}],"balance_after":214718,"source":{"system":"sec-edgar","filing":"0001193125-26-418114","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820590/000119312526418114/ownership.xml","form_type":"4"}},{"id":3525817,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-09-08T20:30:03.000Z","date":"2026-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":460,"price":9.05,"value":4163.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying the restricted stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":59465,"source":{"system":"sec-edgar","filing":"0001193125-26-385250","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312526385250/ownership.xml","form_type":"4"}},{"id":708267,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-16T20:30:48.000Z","date":"2026-07-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1555,"price":11.035,"value":17159.425,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying the restricted stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":59925,"source":{"system":"sec-edgar","filing":"0001193125-26-306165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312526306165/ownership.xml","form_type":"4"}},{"id":761184,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-27T16:30:15.000Z","date":"2026-05-22","kind":"gift","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects shares transferred for no consideration to a trust for the benefit of the Reporting Person's spouse and for which the Reporting Person serves as trustee."}],"balance_after":148500,"source":{"system":"sec-edgar","filing":"0001193125-26-241984","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312526241984/ownership.xml","form_type":"4"}},{"id":761183,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-27T16:30:15.000Z","date":"2026-05-22","kind":"gift","planned":false,"acquired":false,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24122,"source":{"system":"sec-edgar","filing":"0001193125-26-241984","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312526241984/ownership.xml","form_type":"4"}},{"id":767591,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":26591,"kind":"person","name":"Topper James N","position":1,"cik":"0001341382","reported_name":"Topper James N","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T20:30:16.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":24122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were granted on May 19, 2026, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":66718,"source":{"system":"sec-edgar","filing":"0001193125-26-234572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341382/000119312526234572/ownership.xml","form_type":"4"}},{"id":768060,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":45258,"kind":"person","name":"Stenhouse Mark","position":1,"cik":"0001734751","reported_name":"Stenhouse Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T20:30:11.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":24122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were granted on May 19, 2026, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":54122,"source":{"system":"sec-edgar","filing":"0001193125-26-234568","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734751/000119312526234568/ownership.xml","form_type":"4"}},{"id":768758,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":45416,"kind":"person","name":"FIELDS HEIDI","position":1,"cik":"0001014330","reported_name":"FIELDS HEIDI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T20:30:10.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":24122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were granted on May 19, 2026, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":54122,"source":{"system":"sec-edgar","filing":"0001193125-26-234567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1014330/000119312526234567/ownership.xml","form_type":"4"}},{"id":767664,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":45168,"kind":"person","name":"COLA MICHAEL F","position":1,"cik":"0001188940","reported_name":"COLA MICHAEL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T20:30:08.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":24122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were granted on May 19, 2026, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":63920,"source":{"system":"sec-edgar","filing":"0001193125-26-234566","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188940/000119312526234566/ownership.xml","form_type":"4"}},{"id":767631,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":45159,"kind":"person","name":"KARBE FRANK","position":1,"cik":"0001276700","reported_name":"KARBE FRANK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T20:30:05.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":24122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were granted on May 19, 2026, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":91622,"source":{"system":"sec-edgar","filing":"0001193125-26-234564","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276700/000119312526234564/ownership.xml","form_type":"4"}},{"id":767742,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":45189,"kind":"person","name":"Schroeder Theodore R","position":1,"cik":"0001378690","reported_name":"Schroeder Theodore R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T20:30:04.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":24122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were granted on May 19, 2026, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":45122,"source":{"system":"sec-edgar","filing":"0001193125-26-234563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378690/000119312526234563/ownership.xml","form_type":"4"}},{"id":767338,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2026-05-21T17:16:32.000Z","date":"2026-05-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.95,"exercise_date":"2026-05-19","expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001193125-26-234891","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312526234891/ownership.xml","form_type":"4"}},{"id":767337,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T17:16:32.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":true,"shares":17500,"price":4.95,"value":86625.0,"ownership":{"direct":true},"balance_after":52122,"source":{"system":"sec-edgar","filing":"0001193125-26-234891","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312526234891/ownership.xml","form_type":"4"}},{"id":767336,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T17:16:32.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":24122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were granted on May 19, 2026, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":34622,"source":{"system":"sec-edgar","filing":"0001193125-26-234891","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312526234891/ownership.xml","form_type":"4"}},{"id":848009,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-11T18:54:21.000Z","date":"2026-03-10","kind":"gift","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects shares transferred for no consideration to a trust for the benefit of the Reporting Person's spouse and for which the Reporting Person serves as trustee."}],"balance_after":120500,"source":{"system":"sec-edgar","filing":"0001193125-26-102632","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312526102632/ownership.xml","form_type":"4"}},{"id":848008,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-11T18:54:21.000Z","date":"2026-03-10","kind":"gift","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10500,"source":{"system":"sec-edgar","filing":"0001193125-26-102632","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312526102632/ownership.xml","form_type":"4"}},{"id":869119,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-03T22:11:25.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":414,"price":12.56,"value":5199.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares underlying RSUs that were surrendered by the reporting person to the Issuer upon vesting of such RSU in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":61480,"source":{"system":"sec-edgar","filing":"0001193125-26-088730","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312526088730/ownership.xml","form_type":"4"}},{"id":869118,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-03T22:11:25.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":964,"price":12.56,"value":12107.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares underlying the performance stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":61894,"source":{"system":"sec-edgar","filing":"0001193125-26-088730","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312526088730/ownership.xml","form_type":"4"}},{"id":869117,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-03T22:11:25.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":2790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares issued upon vesting of performance stock units granted to the reporting person on February 27, 2025 based on the achievement of performance criteria determined to be satisfied on February 27, 2026."}],"balance_after":62858,"source":{"system":"sec-edgar","filing":"0001193125-26-088730","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312526088730/ownership.xml","form_type":"4"}},{"id":869116,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-03T22:11:25.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on February 27, 2026. 1/3 of the total number of RSUs granted vest on each of the first three anniversaries of February 27, 2026, the vesting commencement date, subject to the Reporting Person's continued service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":60068,"source":{"system":"sec-edgar","filing":"0001193125-26-088730","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312526088730/ownership.xml","form_type":"4"}},{"id":907411,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66695,"kind":"person","name":"Cook Anne Marie","position":1,"cik":"0001320559","reported_name":"Cook Anne Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Off. & Corp. Sec."}}],"security":"Common Stock","published_at":"2026-02-12T16:36:29.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1535,"price":12.82,"value":19678.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares underlying the performance stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":88660,"source":{"system":"sec-edgar","filing":"0001193125-26-048881","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1320559/000119312526048881/ownership.xml","form_type":"4"}},{"id":907410,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66695,"kind":"person","name":"Cook Anne Marie","position":1,"cik":"0001320559","reported_name":"Cook Anne Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Off. & Corp. Sec."}}],"security":"Common Stock","published_at":"2026-02-12T16:36:29.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":3461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued upon vesting of performance stock units granted to the reporting person on June 23, 2025 based on the achievement of performance criteria determined to be satisfied on February 10, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,722 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in January 2026."}],"balance_after":90195,"source":{"system":"sec-edgar","filing":"0001193125-26-048881","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1320559/000119312526048881/ownership.xml","form_type":"4"}},{"id":907458,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-12T16:34:07.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":6277,"price":12.82,"value":80471.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares underlying the performance stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":373315,"source":{"system":"sec-edgar","filing":"0001193125-26-048867","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000119312526048867/ownership.xml","form_type":"4"}},{"id":907457,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-12T16:34:07.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":12362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued upon vesting of performance stock units granted to the reporting person on April 3, 2025 based on the achievement of performance criteria determined to be satisfied on February 10, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,410 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in January 2026."}],"balance_after":379592,"source":{"system":"sec-edgar","filing":"0001193125-26-048867","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000119312526048867/ownership.xml","form_type":"4"}},{"id":929747,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-27T16:38:48.000Z","date":"2026-01-23","kind":"gift","planned":false,"acquired":true,"shares":80500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects shares transferred for no consideration to a trust for the benefit of the Reporting Person's spouse and for which the Reporting Person serves as trustee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are subject to a lock-up agreement entered into by the Reporting Person in connection with the underwriting agreement dated January 7, 2026 (the Lock-Up Agreement). The trust has agreed in writing to be bound by the same terms described in the Lock-Up Agreement to the extent and for the duration that such terms remain in effect at the time of the transfer."}],"balance_after":80500,"source":{"system":"sec-edgar","filing":"0001193125-26-024600","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312526024600/ownership.xml","form_type":"4"}},{"id":929746,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-27T16:38:48.000Z","date":"2026-01-23","kind":"gift","planned":false,"acquired":false,"shares":80500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50500,"source":{"system":"sec-edgar","filing":"0001193125-26-024600","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312526024600/ownership.xml","form_type":"4"}},{"id":932543,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-01-23T21:42:13.000Z","date":"2026-01-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":776,"price":13.61,"value":10561.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying the restricted stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":47068,"source":{"system":"sec-edgar","filing":"0001193125-26-021164","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312526021164/ownership.xml","form_type":"4"}},{"id":938271,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2026-01-15T16:45:03.000Z","date":"2026-01-13","kind":"exercise","planned":false,"acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":10.3,"exercise_date":"2025-05-23","expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001193125-26-014187","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312526014187/ownership.xml","form_type":"4"}},{"id":938270,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-15T16:45:03.000Z","date":"2026-01-13","kind":"exercise","planned":false,"acquired":true,"shares":8750,"price":10.3,"value":90125.0,"ownership":{"direct":true},"balance_after":131000,"source":{"system":"sec-edgar","filing":"0001193125-26-014187","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312526014187/ownership.xml","form_type":"4"}},{"id":955092,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-02T17:46:12.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":226156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the total number of shares of common stock subject to the option vest monthly following the Vesting Commencement Date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":221156,"derivative":{"exercise_price":15.71,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":226156},"source":{"system":"sec-edgar","filing":"0001193125-26-001127","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000119312526001127/ownership.xml","form_type":"4"}},{"id":955091,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-02T17:46:12.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":251034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on January 2, 2026. 1/3 of the total number of RSUs granted vest on each of the first three anniversaries of January 2, 2026, the vesting commencement date (the \"Vesting Commencement Date\"), subject to the Reporting Person's continued service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":364820,"source":{"system":"sec-edgar","filing":"0001193125-26-001127","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000119312526001127/ownership.xml","form_type":"4"}},{"id":955085,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66695,"kind":"person","name":"Cook Anne Marie","position":1,"cik":"0001320559","reported_name":"Cook Anne Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Off. & Corp. Sec."}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-02T17:44:20.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":67878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the total number of shares of common stock subject to the option vest monthly following the Vesting Commencement Date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":67878,"derivative":{"exercise_price":15.71,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":67878},"source":{"system":"sec-edgar","filing":"0001193125-26-001125","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1320559/000119312526001125/ownership.xml","form_type":"4"}},{"id":955084,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66695,"kind":"person","name":"Cook Anne Marie","position":1,"cik":"0001320559","reported_name":"Cook Anne Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Off. & Corp. Sec."}}],"security":"Common Stock","published_at":"2026-01-02T17:44:20.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":75345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on January 2, 2026. 1/3 of the total number of RSUs granted vest on each of the first three anniversaries of January 2, 2026, the vesting commencement date (the \"Vesting Commencement Date\"), subject to the Reporting Person's continued service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":85012,"source":{"system":"sec-edgar","filing":"0001193125-26-001125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1320559/000119312526001125/ownership.xml","form_type":"4"}},{"id":954823,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":70563,"kind":"person","name":"Narula Sanjeev","position":1,"cik":"0001820590","reported_name":"Narula Sanjeev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-02T17:42:34.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":42848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the total number of shares of common stock subject to the option vest monthly following the Vesting Commencement Date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":42848,"derivative":{"exercise_price":15.71,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":42848},"source":{"system":"sec-edgar","filing":"0001193125-26-001123","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312526001123/ownership.xml","form_type":"4"}},{"id":954822,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":70563,"kind":"person","name":"Narula Sanjeev","position":1,"cik":"0001820590","reported_name":"Narula Sanjeev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2026-01-02T17:42:34.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":82715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on January 2, 2026. 1/3 of the total number of RSUs granted vest on each of the first three anniversaries of January 2, 2026, the vesting commencement date (the \"Vesting Commencement Date\"), subject to the Reporting Person's continued service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":226715,"source":{"system":"sec-edgar","filing":"0001193125-26-001123","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312526001123/ownership.xml","form_type":"4"}},{"id":959243,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2025-12-23T17:00:05.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8750,"derivative":{"exercise_price":10.3,"exercise_date":"2025-05-23","expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001193125-25-331104","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312525331104/ownership.xml","form_type":"4"}},{"id":959242,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-23T17:00:05.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":true,"shares":8750,"price":10.3,"value":90125.0,"ownership":{"direct":true},"balance_after":122250,"source":{"system":"sec-edgar","filing":"0001193125-25-331104","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312525331104/ownership.xml","form_type":"4"}},{"id":962279,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-12-19T22:50:58.000Z","date":"2025-12-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":230,"price":16.28,"value":3744.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying the restricted stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":47844,"source":{"system":"sec-edgar","filing":"0001193125-25-327135","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312525327135/ownership.xml","form_type":"4"}},{"id":961935,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66695,"kind":"person","name":"Cook Anne Marie","position":1,"cik":"0001320559","reported_name":"Cook Anne Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Off. & Corp. Sec."}}],"security":"Common Stock","published_at":"2025-12-19T17:47:12.000Z","date":"2025-12-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":7703,"price":15.36,"value":118318.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares underlying the performance stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":9667,"source":{"system":"sec-edgar","filing":"0001193125-25-327131","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1320559/000119312525327131/ownership.xml","form_type":"4"}},{"id":961934,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66695,"kind":"person","name":"Cook Anne Marie","position":1,"cik":"0001320559","reported_name":"Cook Anne Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Off. & Corp. Sec."}}],"security":"Common Stock","published_at":"2025-12-19T17:47:12.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":17370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued upon vesting of performance stock units granted to the reporting person on June 23, 2025 based on the achievement of performance criteria determined to be satisfied on December 17, 2025."}],"balance_after":17370,"source":{"system":"sec-edgar","filing":"0001193125-25-327131","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1320559/000119312525327131/ownership.xml","form_type":"4"}},{"id":961949,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-19T17:45:41.000Z","date":"2025-12-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":31502,"price":15.36,"value":483870.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares underlying the performance stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":113786,"source":{"system":"sec-edgar","filing":"0001193125-25-327126","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000119312525327126/ownership.xml","form_type":"4"}},{"id":961948,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-19T17:45:41.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":62038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued upon vesting of performance stock units granted to the reporting person on April 3, 2025 based on the achievement of performance criteria determined to be satisfied on December 17, 2025."}],"balance_after":145288,"source":{"system":"sec-edgar","filing":"0001193125-25-327126","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000119312525327126/ownership.xml","form_type":"4"}},{"id":983456,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Shares","published_at":"2025-12-02T18:45:22.000Z","date":"2025-11-28","kind":"exercise","planned":false,"acquired":false,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 3, 2025, the reporting person was granted 360,000 performance stock units, of which 90,000 vested on September 25, 2025 and an additional 90,000 vested on November 28, 2025, in each case due to the achievement of the applicable stock price hurdle. The remaining performance stock units will vest based on the achievement of stock price hurdles over a period of four years following the grant date, subject to the reporting person's continued service through the date each such stock price hurdle is achieved."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On April 3, 2025, the reporting person was granted 360,000 performance stock units, of which 90,000 vested on September 25, 2025 and an additional 90,000 vested on November 28, 2025, in each case due to the achievement of the applicable stock price hurdle. The remaining performance stock units will vest based on the achievement of stock price hurdles over a period of four years following the grant date, subject to the reporting person's continued service through the date each such stock price hurdle is achieved."}],"balance_after":180000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001193125-25-305575","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000119312525305575/ownership.xml","form_type":"4"}},{"id":983455,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-02T18:45:22.000Z","date":"2025-11-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":48375,"price":15.62,"value":755617.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying the performance stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":83250,"source":{"system":"sec-edgar","filing":"0001193125-25-305575","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000119312525305575/ownership.xml","form_type":"4"}},{"id":983454,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-02T18:45:22.000Z","date":"2025-11-28","kind":"exercise","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":131625,"source":{"system":"sec-edgar","filing":"0001193125-25-305575","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000119312525305575/ownership.xml","form_type":"4"}},{"id":1006975,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-11-05T21:30:03.000Z","date":"2025-11-03","kind":"sale","planned":false,"acquired":false,"shares":524,"price":13.51,"value":7079.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units."}],"balance_after":47407,"source":{"system":"sec-edgar","filing":"0001193125-25-267057","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000119312525267057/ownership.xml","form_type":"4"}},{"id":1021198,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":70563,"kind":"person","name":"Narula Sanjeev","position":1,"cik":"0001820590","reported_name":"Narula Sanjeev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2025-10-08T17:09:21.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":144000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on October 6, 2025. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of October 6, 2025, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amendment is being filed to report the transaction which was inadvertently omitted in the Form 4 filed on behalf of the Reporting Person on October 7, 2025."}],"balance_after":144000,"source":{"system":"sec-edgar","filing":"0001193125-25-234650","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312525234650/ownership.xml","form_type":"4/A","original_submission_date":"2025-10-07"}},{"id":1021935,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":70563,"kind":"person","name":"Narula Sanjeev","position":1,"cik":"0001820590","reported_name":"Narula Sanjeev","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T17:25:12.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest with respect to 25% of the shares of common stock on October 6, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates."}],"balance_after":200000,"derivative":{"exercise_price":11.61,"expiration_date":"2036-10-05","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001193125-25-233684","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312525233684/ownership.xml","form_type":"4"}},{"id":1031706,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Shares","published_at":"2025-09-26T19:03:39.000Z","date":"2025-09-25","kind":"exercise","planned":false,"acquired":false,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 3, 2025, the reporting person was granted 360,000 performance stock units, of which 90,000 vested on September 25, 2025 due to the achievement of the applicable stock price hurdle. The remaining performance stock units will vest based on the achievement of stock price hurdles over a period of four years following the grant date, subject to the reporting person's continued service through the date each such stock price hurdle is achieved."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On April 3, 2025, the reporting person was granted 360,000 performance stock units, of which 90,000 vested on September 25, 2025 due to the achievement of the applicable stock price hurdle. The remaining performance stock units will vest based on the achievement of stock price hurdles over a period of four years following the grant date, subject to the reporting person's continued service through the date each such stock price hurdle is achieved."}],"balance_after":270000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001193125-25-220950","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000119312525220950/ownership.xml","form_type":"4"}},{"id":1031705,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-09-26T19:03:39.000Z","date":"2025-09-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":48375,"price":11.66,"value":564052.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying the performance stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation."}],"balance_after":41625,"source":{"system":"sec-edgar","filing":"0001193125-25-220950","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000119312525220950/ownership.xml","form_type":"4"}},{"id":1031704,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-09-26T19:03:39.000Z","date":"2025-09-25","kind":"exercise","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":90000,"source":{"system":"sec-edgar","filing":"0001193125-25-220950","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000119312525220950/ownership.xml","form_type":"4"}},{"id":1045014,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-09-09T20:40:19.000Z","date":"2025-09-05","kind":"sale","planned":false,"acquired":false,"shares":461,"price":12.09,"value":5573.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units."}],"balance_after":47931,"source":{"system":"sec-edgar","filing":"0000950170-25-113822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000095017025113822/ownership.xml","form_type":"4"}},{"id":1084818,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-07-18T20:05:07.000Z","date":"2025-07-16","kind":"sale","planned":false,"acquired":false,"shares":1692,"price":8.3639,"value":14151.7188,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in mutliple transactions at prices $8.364 and $8.35. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":48392,"source":{"system":"sec-edgar","filing":"0000950170-25-096917","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000095017025096917/ownership.xml","form_type":"4"}},{"id":1102571,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66695,"kind":"person","name":"Cook Anne Marie","position":1,"cik":"0001320559","reported_name":"Cook Anne Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Off. & Corp. Sec."}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T17:00:07.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest with respect to 25% of the shares of common stock on June 23, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates."}],"balance_after":210000,"derivative":{"exercise_price":9.47,"expiration_date":"2035-06-22","underlying":"Common Stock","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0000950170-25-089513","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1320559/000095017025089513/ownership.xml","form_type":"4"}},{"id":1121035,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":45159,"kind":"person","name":"KARBE FRANK","position":1,"cik":"0001276700","reported_name":"KARBE FRANK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:58:25.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date."}],"balance_after":17500,"derivative":{"exercise_price":4.95,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-25-082458","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276700/000095017025082458/ownership.xml","form_type":"4"}},{"id":1121034,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":45159,"kind":"person","name":"KARBE FRANK","position":1,"cik":"0001276700","reported_name":"KARBE FRANK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:58:25.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were granted on June 3, 2025, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":67500,"source":{"system":"sec-edgar","filing":"0000950170-25-082458","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276700/000095017025082458/ownership.xml","form_type":"4"}},{"id":1121074,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":45168,"kind":"person","name":"COLA MICHAEL F","position":1,"cik":"0001188940","reported_name":"COLA MICHAEL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:58:12.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date."}],"balance_after":17500,"derivative":{"exercise_price":4.95,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-25-082456","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1188940/000095017025082456/ownership.xml","form_type":"4"}},{"id":1121073,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":45168,"kind":"person","name":"COLA MICHAEL F","position":1,"cik":"0001188940","reported_name":"COLA MICHAEL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:58:12.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were granted on June 3, 2025, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":39798,"source":{"system":"sec-edgar","filing":"0000950170-25-082456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188940/000095017025082456/ownership.xml","form_type":"4"}},{"id":1121001,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":26591,"kind":"person","name":"Topper James N","position":1,"cik":"0001341382","reported_name":"Topper James N","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:56:34.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the firstanniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vestingdate."}],"balance_after":17500,"derivative":{"exercise_price":4.95,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-25-082454","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1341382/000095017025082454/ownership.xml","form_type":"4"}},{"id":1121000,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":26591,"kind":"person","name":"Topper James N","position":1,"cik":"0001341382","reported_name":"Topper James N","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:56:34.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were granted on June 3, 2025, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":42596,"source":{"system":"sec-edgar","filing":"0000950170-25-082454","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341382/000095017025082454/ownership.xml","form_type":"4"}},{"id":1121936,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":45416,"kind":"person","name":"FIELDS HEIDI","position":1,"cik":"0001014330","reported_name":"FIELDS HEIDI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:56:32.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date."}],"balance_after":17500,"derivative":{"exercise_price":4.95,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-25-082453","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1014330/000095017025082453/ownership.xml","form_type":"4"}},{"id":1121935,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":45416,"kind":"person","name":"FIELDS HEIDI","position":1,"cik":"0001014330","reported_name":"FIELDS HEIDI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:56:32.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were granted on June 3, 2025, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0000950170-25-082453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1014330/000095017025082453/ownership.xml","form_type":"4"}},{"id":1121421,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":45258,"kind":"person","name":"Stenhouse Mark","position":1,"cik":"0001734751","reported_name":"Stenhouse Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:55:05.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date."}],"balance_after":17500,"derivative":{"exercise_price":4.95,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-25-082448","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734751/000095017025082448/ownership.xml","form_type":"4"}},{"id":1121420,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":45258,"kind":"person","name":"Stenhouse Mark","position":1,"cik":"0001734751","reported_name":"Stenhouse Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:55:05.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were granted on June 3, 2025, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0000950170-25-082448","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734751/000095017025082448/ownership.xml","form_type":"4"}},{"id":1120838,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T16:54:33.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date."}],"balance_after":17500,"derivative":{"exercise_price":4.95,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-25-082445","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000095017025082445/ownership.xml","form_type":"4"}},{"id":1120837,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T16:54:33.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were granted on June 3, 2025, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":113500,"source":{"system":"sec-edgar","filing":"0000950170-25-082445","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000095017025082445/ownership.xml","form_type":"4"}},{"id":1134909,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":26591,"kind":"person","name":"Topper James N","position":1,"cik":"0001341382","reported_name":"Topper James N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-23T20:06:35.000Z","date":"2025-05-21","kind":"purchase","planned":false,"acquired":true,"shares":3780,"price":3.8649,"value":14609.322,"ownership":{"direct":false,"nature":"By Frazier Life Sciences X, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.76 to $3.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares reported herein are held of record by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":59403,"source":{"system":"sec-edgar","filing":"0001415889-25-014428","document":"form4-05232025_080527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341382/000141588925014428/form4-05232025_080527.xml","form_type":"4"}},{"id":1139255,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":30132,"kind":"person","name":"Breedlove Robert Charles","position":1,"cik":"0002066645","reported_name":"Breedlove Robert Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-21T21:17:36.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest with respect to 25% of the shares of common stock on May 19, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates."}],"balance_after":33000,"derivative":{"exercise_price":4.39,"expiration_date":"2035-05-18","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0000950170-25-075870","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066645/000095017025075870/ownership.xml","form_type":"4"}},{"id":1147096,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":26591,"kind":"person","name":"Topper James N","position":1,"cik":"0001341382","reported_name":"Topper James N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-15T20:17:38.000Z","date":"2025-05-14","kind":"purchase","planned":false,"acquired":true,"shares":6300,"price":3.3205,"value":20919.15,"ownership":{"direct":false,"nature":"By Frazier Life Sciences X, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.215 to $3.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares reported herein are held of record by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":55623,"source":{"system":"sec-edgar","filing":"0001415889-25-013134","document":"form4-05152025_080534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341382/000141588925013134/form4-05152025_080534.xml","form_type":"4"}},{"id":1147095,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":26591,"kind":"person","name":"Topper James N","position":1,"cik":"0001341382","reported_name":"Topper James N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-15T20:17:38.000Z","date":"2025-05-13","kind":"purchase","planned":false,"acquired":true,"shares":1120,"price":3.1637,"value":3543.344,"ownership":{"direct":false,"nature":"By Frazier Life Sciences X, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.045 to $3.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares reported herein are held of record by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":49323,"source":{"system":"sec-edgar","filing":"0001415889-25-013134","document":"form4-05152025_080534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341382/000141588925013134/form4-05152025_080534.xml","form_type":"4"}},{"id":1150540,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":26591,"kind":"person","name":"Topper James N","position":1,"cik":"0001341382","reported_name":"Topper James N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-13T20:13:04.000Z","date":"2025-05-12","kind":"purchase","planned":false,"acquired":true,"shares":12601,"price":3.0395,"value":38300.7395,"ownership":{"direct":false,"nature":"By Frazier Life Sciences X, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.825 to $3.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (4) to this Form 4"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares reported herein are held of record by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":48203,"source":{"system":"sec-edgar","filing":"0001415889-25-012770","document":"form4-05132025_080500.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341382/000141588925012770/form4-05132025_080500.xml","form_type":"4"}},{"id":1150539,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":26591,"kind":"person","name":"Topper James N","position":1,"cik":"0001341382","reported_name":"Topper James N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-13T20:13:04.000Z","date":"2025-05-09","kind":"purchase","planned":false,"acquired":true,"shares":2226,"price":3.6177,"value":8053.0002,"ownership":{"direct":false,"nature":"By Frazier Life Sciences X, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.58 to $3.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares reported herein are held of record by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":35602,"source":{"system":"sec-edgar","filing":"0001415889-25-012770","document":"form4-05132025_080500.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341382/000141588925012770/form4-05132025_080500.xml","form_type":"4"}},{"id":1150538,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":26591,"kind":"person","name":"Topper James N","position":1,"cik":"0001341382","reported_name":"Topper James N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-13T20:13:04.000Z","date":"2025-05-09","kind":"purchase","planned":false,"acquired":true,"shares":33376,"price":3.1928,"value":106562.8928,"ownership":{"direct":false,"nature":"By Frazier Life Sciences X, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.575 to $3.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares reported herein are held of record by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":33376,"source":{"system":"sec-edgar","filing":"0001415889-25-012770","document":"form4-05132025_080500.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341382/000141588925012770/form4-05132025_080500.xml","form_type":"4"}},{"id":1154794,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-08T17:27:00.000Z","date":"2025-05-07","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2.3969,"value":11984.5,"ownership":{"direct":true},"balance_after":95500,"source":{"system":"sec-edgar","filing":"0000950170-25-067237","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000095017025067237/ownership.xml","form_type":"4"}},{"id":1154793,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-08T17:27:00.000Z","date":"2025-05-06","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2.6,"value":13000.0,"ownership":{"direct":true},"balance_after":90500,"source":{"system":"sec-edgar","filing":"0000950170-25-067237","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000095017025067237/ownership.xml","form_type":"4"}},{"id":1170926,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":45189,"kind":"person","name":"Schroeder Theodore R","position":1,"cik":"0001378690","reported_name":"Schroeder Theodore R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2025-04-16T21:44:03.000Z","date":"2025-04-16","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest with respect to one-third (1/3) of the shares of common stock on April 16, 2026, and will vest in substantially equal quarterly installments over the twenty-four (24) months thereafter, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates."}],"balance_after":35000,"derivative":{"exercise_price":4.23,"expiration_date":"2035-04-15","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000950170-25-054886","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1378690/000095017025054886/ownership.xml","form_type":"4"}},{"id":1170925,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":45189,"kind":"person","name":"Schroeder Theodore R","position":1,"cik":"0001378690","reported_name":"Schroeder Theodore R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-16T21:44:03.000Z","date":"2025-04-16","kind":"grant","planned":false,"acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on April 16, 2025. One-third (1/3) of the total number of RSUs granted vest on April 16, 2026, and will vest in substantially equal quarterly installments over the twenty-four (24) months thereafter, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":21000,"source":{"system":"sec-edgar","filing":"0000950170-25-054886","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1378690/000095017025054886/ownership.xml","form_type":"4"}},{"id":1175317,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":80954,"kind":"person","name":"Henderson Molly","position":1,"cik":"0001363812","reported_name":"Henderson Molly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Common Stock","published_at":"2025-04-08T17:01:33.000Z","date":"2025-04-07","kind":"sale","planned":false,"acquired":false,"shares":3678,"price":4.5513,"value":16739.6814,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in two transactions at prices $4.55 to $4.57. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":89868,"source":{"system":"sec-edgar","filing":"0000950170-25-052156","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363812/000095017025052156/ownership.xml","form_type":"4"}},{"id":1179300,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-03T17:30:02.000Z","date":"2025-04-03","kind":"grant","planned":false,"acquired":true,"shares":1085000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest with respect to 25% of the shares of common stock on April 3, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates."}],"balance_after":1085000,"derivative":{"exercise_price":5.01,"expiration_date":"2035-04-02","underlying":"Common Stock","underlying_shares":1085000},"source":{"system":"sec-edgar","filing":"0000950170-25-050621","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000095017025050621/ownership.xml","form_type":"4"}},{"id":1179299,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Shares","published_at":"2025-04-03T17:30:02.000Z","date":"2025-04-03","kind":"grant","planned":false,"acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The performance stock units will vest based on the achievement of stock price hurdles and service-based vesting requirements over a period of four years following the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The performance stock units will vest based on the achievement of stock price hurdles and service-based vesting requirements over a period of four years following the grant date."}],"balance_after":360000,"derivative":{"underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0000950170-25-050621","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000095017025050621/ownership.xml","form_type":"4"}},{"id":1194372,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-21T16:46:34.000Z","date":"2024-09-10","kind":"exercise","planned":false,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7500,"derivative":{"exercise_price":11.72,"exercise_date":"2024-05-25","expiration_date":"2033-05-24","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000950170-25-043291","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000095017025043291/ownership.xml","form_type":"4"}},{"id":1194371,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-21T16:46:34.000Z","date":"2024-09-10","kind":"exercise","planned":false,"acquired":true,"shares":7500,"price":11.72,"value":87900.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The amount in column 5 shows the amount beneficially owned as of the filing date of this report."}],"balance_after":93000,"source":{"system":"sec-edgar","filing":"0000950170-25-043291","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000095017025043291/ownership.xml","form_type":"4"}},{"id":1203156,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-17T16:27:25.000Z","date":"2025-03-13","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.42,"value":44200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.29 to $4.55. The reporting person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":85500,"source":{"system":"sec-edgar","filing":"0000950170-25-040325","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000095017025040325/ownership.xml","form_type":"4"}},{"id":1235875,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":18725,"kind":"person","name":"Curran Terrie","position":1,"cik":"0001690298","reported_name":"Curran Terrie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Chief Executive"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-03T22:16:33.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":342500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest with respect to 25% of the shares of common stock on February 27, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates."}],"balance_after":342500,"derivative":{"exercise_price":5.76,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":342500},"source":{"system":"sec-edgar","filing":"0000950170-25-031048","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690298/000095017025031048/ownership.xml","form_type":"4"}},{"id":1235370,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":80954,"kind":"person","name":"Henderson Molly","position":1,"cik":"0001363812","reported_name":"Henderson Molly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-03T17:15:30.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest with respect to 25% of the shares of common stock on February 27, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates."}],"balance_after":50000,"derivative":{"exercise_price":5.76,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-25-031042","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1363812/000095017025031042/ownership.xml","form_type":"4"}},{"id":1235369,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":80954,"kind":"person","name":"Henderson Molly","position":1,"cik":"0001363812","reported_name":"Henderson Molly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Common Stock","published_at":"2025-03-03T17:15:30.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on February 27, 2025. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of February 27, 2025, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":165546,"source":{"system":"sec-edgar","filing":"0000950170-25-031042","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363812/000095017025031042/ownership.xml","form_type":"4"}},{"id":1235070,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":82552,"kind":"person","name":"Nabulsi Azmi","position":1,"cik":"0001791412","reported_name":"Nabulsi Azmi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-03T17:13:45.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest with respect to 25% of the shares of common stock on February 27, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates."}],"balance_after":55000,"derivative":{"exercise_price":5.76,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0000950170-25-031034","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000095017025031034/ownership.xml","form_type":"4"}},{"id":1235069,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":82552,"kind":"person","name":"Nabulsi Azmi","position":1,"cik":"0001791412","reported_name":"Nabulsi Azmi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-03-03T17:13:45.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":79200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on February 27, 2025. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of February 27, 2025, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":312590,"source":{"system":"sec-edgar","filing":"0000950170-25-031034","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000095017025031034/ownership.xml","form_type":"4"}},{"id":1296405,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":18725,"kind":"person","name":"Curran Terrie","position":1,"cik":"0001690298","reported_name":"Curran Terrie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Chief Executive"}}],"security":"Common Stock","published_at":"2025-01-23T21:19:11.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":19109,"price":6.5877,"value":125884.3593,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.5855 to $6.6503. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,840 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in January 2025."}],"balance_after":360465,"source":{"system":"sec-edgar","filing":"0000950170-25-008348","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690298/000095017025008348/ownership.xml","form_type":"4"}},{"id":1296234,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":80954,"kind":"person","name":"Henderson Molly","position":1,"cik":"0001363812","reported_name":"Henderson Molly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Common Stock","published_at":"2025-01-23T16:24:08.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":6583,"price":6.5883,"value":43370.7789,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in two transactions at prices $6.5855 to $6.6519. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,973 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in January 2025."}],"balance_after":93546,"source":{"system":"sec-edgar","filing":"0000950170-25-008357","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363812/000095017025008357/ownership.xml","form_type":"4"}},{"id":1296117,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":82552,"kind":"person","name":"Nabulsi Azmi","position":1,"cik":"0001791412","reported_name":"Nabulsi Azmi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-01-23T16:21:10.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":7886,"price":6.5885,"value":51956.911,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.5855 to $6.6650. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,973 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in January 2025."}],"balance_after":233390,"source":{"system":"sec-edgar","filing":"0000950170-25-008353","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000095017025008353/ownership.xml","form_type":"4"}},{"id":1323788,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":82552,"kind":"person","name":"Nabulsi Azmi","position":1,"cik":"0001791412","reported_name":"Nabulsi Azmi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-12-20T16:21:13.000Z","date":"2024-12-19","kind":"sale","planned":false,"acquired":false,"shares":1118,"price":8,"value":8944.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units."}],"balance_after":239303,"source":{"system":"sec-edgar","filing":"0000950170-24-139063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000095017024139063/ownership.xml","form_type":"4"}},{"id":1323933,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":80954,"kind":"person","name":"Henderson Molly","position":1,"cik":"0001363812","reported_name":"Henderson Molly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Common Stock","published_at":"2024-12-20T16:20:21.000Z","date":"2024-12-19","kind":"sale","planned":false,"acquired":false,"shares":1291,"price":8,"value":10328.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units."}],"balance_after":98156,"source":{"system":"sec-edgar","filing":"0000950170-24-139062","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363812/000095017024139062/ownership.xml","form_type":"4"}},{"id":1330616,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":45159,"kind":"person","name":"KARBE FRANK","position":1,"cik":"0001276700","reported_name":"KARBE FRANK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-16T13:05:06.000Z","date":"2024-12-13","kind":"purchase","planned":false,"acquired":true,"shares":12500,"price":7.9267,"value":99083.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.87 to $8.00. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":57000,"source":{"system":"sec-edgar","filing":"0000950170-24-136391","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276700/000095017024136391/ownership.xml","form_type":"4"}},{"id":1330432,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":43735,"kind":"person","name":"Parikh Asit","position":1,"cik":"0001796787","reported_name":"Parikh Asit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-16T08:05:05.000Z","date":"2024-12-13","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":8.1248,"value":81248.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.9999 to $8.2496. The reporting person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":75500,"source":{"system":"sec-edgar","filing":"0000950170-24-136390","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000095017024136390/ownership.xml","form_type":"4"}},{"id":1452612,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":18725,"kind":"person","name":"Curran Terrie","position":1,"cik":"0001690298","reported_name":"Curran Terrie","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and Chief Executive"}}],"security":"Common Stock","published_at":"2024-07-17T18:50:07.000Z","date":"2024-07-15","kind":"sale","planned":false,"acquired":false,"shares":33848,"price":11.72,"value":396698.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 798 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2024."}],"balance_after":377734,"source":{"system":"sec-edgar","filing":"0000950170-24-084179","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690298/000095017024084179/ownership.xml","form_type":"4"}},{"id":1452258,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":82552,"kind":"person","name":"Nabulsi Azmi","position":1,"cik":"0001791412","reported_name":"Nabulsi Azmi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-07-17T14:52:30.000Z","date":"2024-07-15","kind":"sale","planned":false,"acquired":false,"shares":10901,"price":11.72,"value":127759.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,754 shares acquired in January 2024 and 1 share acquired in July 2024 under the Phathom Pharmaceuticals, Inc. employee stock purchase plan"}],"balance_after":240421,"source":{"system":"sec-edgar","filing":"0000950170-24-084186","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000095017024084186/ownership.xml","form_type":"4"}},{"id":1452359,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":80954,"kind":"person","name":"Henderson Molly","position":1,"cik":"0001363812","reported_name":"Henderson Molly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Common Stock","published_at":"2024-07-17T14:51:21.000Z","date":"2024-07-15","kind":"sale","planned":false,"acquired":false,"shares":4325,"price":11.72,"value":50689.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,009 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2024."}],"balance_after":99447,"source":{"system":"sec-edgar","filing":"0000950170-24-084182","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363812/000095017024084182/ownership.xml","form_type":"4"}},{"id":1496399,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":45159,"kind":"person","name":"KARBE FRANK","position":1,"cik":"0001276700","reported_name":"KARBE FRANK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-31T20:30:28.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":10.1645,"value":254112.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.1016 to $10.20. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44500,"source":{"system":"sec-edgar","filing":"0000950170-24-067365","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276700/000095017024067365/ownership.xml","form_type":"4"}},{"id":1496382,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":80954,"kind":"person","name":"Henderson Molly","position":1,"cik":"0001363812","reported_name":"Henderson Molly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Common Stoock","published_at":"2024-05-31T18:37:55.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on May 31, 2024. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of December 18, 2023, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":102763,"source":{"system":"sec-edgar","filing":"0000950170-24-067548","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1363812/000095017024067548/ownership.xml","form_type":"4"}}],"next_cursor":"2024-05-31T18:37:55.000000Z,1496382"}